Sciences de la vie - soins de santé

Bienvenue sur la page d'accueil sciences de la vie - soins de santé de Law-Now.

Sur cette page, vous pouvez accéder à des articles et des publications relatifs au sciences de la vie - soins de santé, rédigés par les experts de CMS.

Pour rester informés des dernières évolutions, veuillez ajouter cette page à vos favoris sur votre mobile ou vous inscrire pour recevoir les eAlerts.

eAlerts Récentes

  •  
    12.09.2023
    United Kingdom

    UK Re-joins Horizon Europe

    On 7 September, the UK re-joined the world’s largest research collaboration programme, Horizon Europe. The decision has been welcomed by academics and life sciences businesses within the UK and the EU with hopes it will foster greater cross border collaboration between researchers after the UK’s three-year hiatus, enabling UK scientists to re-join the international research networks that they had built up over decades. From this date UK researchers are once again able to apply for grants from a pot of over € 95bn (£81 bn) and bid to take part in projects with certainty...
    Lire la suite
  •  
    15.08.2023
    Europe

    AI in healthcare inventions – technical or not technical?

    SummaryRecent European Patent Office (EPO) Board of Appeal case T 1910/20 sits among a number of decisions regarding the discussion of what constitutes technical character in the field of healthcare. In this case, building a therapy plan, which should not be confused with practising a method of therapy on the human body, was held to be “a purely intellectual exercise”. Physiological measurements (glucose data signals from a patient), did not make the claimed mathematical algorithm have a technical effect.  This case is of further interest since the Board felt it necessary to comment...
    Lire la suite
  •  
    08.08.2023
    Chine

    Circular on the Work Relating to the Im­ple­men­ta­tion of GB 9706.1-2020 and Supporting Concurrent Standards and Special Standards

    The National Medical Products Administration (“NMPA”) issued the Circular on the Work Relating to the Implementation of GB 9706.1-2020 and Supporting Concurrent Standards and Special Standards (No. 14 of 2023, hereinafter referred to as the “Circular”) on 16 March 2023. NMPA also released two interpretation documents relating to the Circular respectively on 16 March 2023 (“NMPA Interpretation I”) and 7 April 2023 (“NMPA Interpretation II”).The national standard GB 9706.1-2020 (the General Requirements for Medical Electrical Equipment Part 1: Basic...
    Lire la suite
  •  
    21.07.2023
    Hongrie

    Hungary’s pharma authority to merge with the National Public Health Centre

    From 1 August 2023, the National Institute of Pharmacy and Nutrition (OGYÉI) will cease to exist as an individual authority and will merge with the National Public Health Centre (NNK), as published in Government Decree No. 333/2023. (VII. 20.).As a result of the merger, the NNK will be renamed the National Centre for Public Health and Pharmacy (Nemzeti Népegészségügyi és Gyógyszerészeti Központ, NNGYK) and will be led by Hungary’s chief medical officer, Cecilia Müller.The new authority will fall under the governance of the minister...
    Lire la suite
  •  
    14.07.2023
    United Kingdom

    (Un)Rea­so­nable alternative treatment – In the Eyes of the MD Holder - The Supreme Court rows back on Montgomery consent

    The case of McCulloch and others (Appellants) v Forth Valley Health Board (Respondent) (Scotland) [2023] UKSC 26 is significant as it addresses the appropriate legal test when looking at what constitutes “reasonable alternative treatment”. The Supreme Court unanimously dismissed the appeal and found that the professional practice test set out in Bolam v Friern Barnet Hospital Management Committee [1957] 1 WLR 582 (“Bolam”) is the correct legal test in determining  a doctor’s responsibility to discuss reasonable treatment options when obtaining a patient’s...
    Lire la suite
  •  
    28.06.2023
    EU, UK

    UK announces £21m AI roll-out across NHS

    IntroductionOn 23 June 2023, the UK government announced a £21 million fund aimed at accelerating the deployment of Artificial Intelligence (“AI”) across the National Health Service (“NHS”). NHS Trusts will have the opportunity to apply for funding to implement promising AI imaging and decision support tools, enabling faster diagnosis and treatment for conditions such as cancer, stroke, and heart disease. Additionally, the government has committed to deploying AI decision support tools in all stroke networks by the end of 2023, increasing the accessibility of stroke...
    Lire la suite